Terms: = Sarcomas AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
51 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Carboxypeptidase Vitellogenic-Like Promotes the Proliferation and Metastasis of Osteosarcoma through the TGF-β/Smad Signaling Pathway.
Wang L; Piao L; Yuan X; Tong L; Han X; Wang J; Shi D; Shao S; Xu X; Zhuang M; Cheng D; Liu Z
Ann Clin Lab Sci; 2023 Nov; 53(6):890-904. PubMed ID: 38182149
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of a novel NAD
Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
[TBL] [Abstract] [Full Text] [Related]
4. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
5. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.
Kobayashi Y; Yokoi A; Hashimura M; Oguri Y; Konno R; Matsumoto T; Tochimoto M; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Am J Pathol; 2023 Aug; 193(8):1116-1128. PubMed ID: 37169340
[TBL] [Abstract] [Full Text] [Related]
6. The mechanism of VCP-mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway.
Li AA; Zhang Y; Li F; Zhou Y; Liu ZL; Long XH
Clin Transl Oncol; 2023 Mar; 25(3):653-661. PubMed ID: 36284060
[TBL] [Abstract] [Full Text] [Related]
7. P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model.
Cruz-Morande S; Dotor J; San-Julian M
Curr Oncol; 2022 Apr; 29(4):2650-2661. PubMed ID: 35448191
[TBL] [Abstract] [Full Text] [Related]
8. LINC00266-1/miR-548c-3p/smad2 feedback loop stimulates the development of osteosarcoma.
Zheng S; Wan L; Ge D; Jiang F; Qian Z; Tang J; Yang J; Yao Y; Yan J; Zhao L; Li H; Yang L
Cell Death Dis; 2020 Jul; 11(7):576. PubMed ID: 32709857
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract] [Full Text] [Related]
10. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
Chen G; Wang M; Liu X
Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of ERβ inhibits the proliferation through regulating TNG-β signaling pathway in osteosarcoma.
Zhang Y; Zhou X; Yin C; Wu Y; Wang L
Pathol Res Pract; 2019 Oct; 215(10):152568. PubMed ID: 31383536
[TBL] [Abstract] [Full Text] [Related]
12. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
[TBL] [Abstract] [Full Text] [Related]
14. A Feedback Loop between Hypoxia and Matrix Stress Relaxation Increases Oxygen-Axis Migration and Metastasis in Sarcoma.
Lewis DM; Pruitt H; Jain N; Ciccaglione M; McCaffery JM; Xia Z; Weber K; Eisinger-Mathason TSK; Gerecht S
Cancer Res; 2019 Apr; 79(8):1981-1995. PubMed ID: 30777851
[TBL] [Abstract] [Full Text] [Related]
15. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract] [Full Text] [Related]
16. Platelet-Derived TGF-β Induces Tissue Factor Expression via the Smad3 Pathway in Osteosarcoma Cells.
Saito M; Ichikawa J; Ando T; Schoenecker JG; Ohba T; Koyama K; Suzuki-Inoue K; Haro H
J Bone Miner Res; 2018 Nov; 33(11):2048-2058. PubMed ID: 29949655
[TBL] [Abstract] [Full Text] [Related]
17. ING5 is a Potential Target for Osteosarcoma Therapy.
Zhang X; Xu ZH; Xie H; Sun YW; Liu J; Zhao YB
Technol Cancer Res Treat; 2018 Jan; 17():1533033818762680. PubMed ID: 29528777
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Significance of omental Disease and the Role of Omental Sampling in Patients With Uterine Carcinosarcoma.
Ross MS; Elishaev E; Berger JL; Kelley JL; Taylor SE
Int J Gynecol Cancer; 2018 Feb; 28(2):254-259. PubMed ID: 29303931
[TBL] [Abstract] [Full Text] [Related]
19. Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression.
Zhao X; Yang Y; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Jan; 39(1):289-297. PubMed ID: 29115549
[TBL] [Abstract] [Full Text] [Related]
20. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
[TBL] [Abstract] [Full Text] [Related]
[Next]
